Jeena Sikho Lifecare Limited has announced a proposal to establish a new Ayurvedic, Naturopathy and Panchkarma Hospital in Kalyani, West Bengal, as part of its expansion strategy. The new facility, located at Plot No. B-11/114, B-11 Block, District Nadia, is expected to commence operations in October 2026 with an estimated bed capacity of over 60. The project entails an investment of approximately ₹1.30 Crores, which will be financed through the company's internal finance and owned funds.

The disclosure was made to the National Stock Exchange of India Limited and BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that the move aims to expand its healthcare network and offer quality Panchakarma services to a larger population in line with its strategic objectives.

Project Details

The proposed hospital unit will span an estimated area of 13,000 sq. ft. The establishment of this facility marks a significant step in the company's efforts to increase its footprint in the healthcare sector. The specific details of the proposed capacity addition are outlined below:

The information regarding the new facility has been made available on the company's official website. The Managing Director, Manish Grover, signed the disclosure on behalf of Jeena Sikho Lifecare on July 22, 2026.

jeena sikho lifecare has announced the publication of two case studies authored by its research officers and professionals in the International Journal of Advanced Research (IJAR). The studies, authored by the Managing Director, senior consultants, and Ayurvedic experts, focus on the Ayurvedic management of kidney disorders. This initiative highlights the company's commitment to Ayurvedic research and evidence-based clinical practice.

The first case study, titled "Ayurvedic Management of Chronic Kidney Disease (Vrikka Vikara) with Reference to Mutravah Sroto Dushti: A Case Study," explores treatment methodologies for chronic kidney conditions. The second study, "Role of Ayurveda in The Management of Vrikka Vikar (Kidney Disorders): A Case Study," further examines the efficacy of Ayurvedic interventions for renal health issues.

Details of Published Case Studies

The disclosure was made to the National Stock Exchange of India Limited and BSE Limited on July 20, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information is also available on the company's official website.